Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.

ABSTRACT:

Objective

Pharmacogenomics seeks to improve prescribing by reducing drug inefficacy/toxicity. However, views of patients during pharmacogenomic-guided care are largely unknown. We sought to understand the attitudes and perceptions of patients in an institutional implementation project and hypothesized that views would differ on the basis of experience with pharmacogenomic-guided care.

Methods

Two focus groups were conducted - one group included patients who had previously been subjected to broad pharmacogenomic genotyping with results available to physicians (pharmacogenomic group), whereas the other had not been offered genotyping (traditional care). Five domains were explored: (i) experiences with medications/side effects, (ii) understanding of pharmacogenomics, (iii) impa

SUBMITTER: Lee YM 

PROVIDER: S-EPMC5478379 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature